Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer Statistics, 2022.CA: A Cancer J Clinicians. 2022; 72: 7-33
American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2022-2024. Atlanta: American Cancer Society; 2022.
National Cancer Institute. Office of Cancer Survivorship. Accessed2022.
- Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment.J Clin Oncol. 2020; 38: 2341-2350
- Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?.Int J Radiat Oncol Biol Phys. 2019; 103: 62-70
- Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery.J Clin Oncol. 2017; 35: 3934-3941
- Survivorship, Version 1.2021.J Natl Compr Canc Netw. 2021; 19: 676-685
- Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2018; 16: 1216-1247
- The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial.Breast Cancer Res Treat. 2004; 86: 95-106
- Manual lymphatic drainage for lymphedema following breast cancer treatment.Cochrane Database Syst Rev. 2015; : CD003475
- Intermittent pneumatic compression pump for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials.Oncol Res Treat. 2014; 37: 170-174
- Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial.JAMA. 2010; 304: 2699-2705
- Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial.JAMA Oncol. 2019; 5: 1605-1613
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.J Natl Cancer Inst. 2018; 110
- Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.JAMA. 2013; 309: 1359-1367
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.J Clin Oncol. 2020; 38: 3325-3348
- Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis.J Pain Symptom Manage. 2021; 61: 1247-1253
- Hot flashes in breast cancer survivors: Frequency, severity and impact.Breast. 2016; 27: 116-121
- An intensive behavioral weight loss intervention and hot flushes in women.Arch Intern Med. 2010; 170: 1161-1167
- Exercise for vasomotor menopausal symptoms.Cochrane Database Syst Rev. 2014; 11: CD006108
- steering H, data monitoring c. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.Lancet. 2004; 363: 453-455
- Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.Lancet. 2000; 356: 2059-2063
- Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.J Clin Oncol. 2010; 28: 3278-3283
- Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.JAMA. 2011; 305: 267-274
- Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).JNCI Cancer Spectr. 2020; 4: pkz088
- Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.J Clin Oncol. 2010; 28: 5147-5152
- The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial.Complement Ther Med. 2020; 48: 102267
- Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.J Clin Oncol. 1998; 16: 495-500
- Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT).J Clin Oncol. 2016; 34: 1795-1802
- Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin.Pain Med. 2014; 15: 410-417
- Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors.Cancer Manag Res. 2018; 10: 4831-4837
- Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.Menopause. 2014; 21: 807-814
- Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.J Clin Oncol. 2008; 26: 5022-5026
- Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.Menopause. 2013; 20: 291-298
- Missing documentation in breast cancer survivors: genitourinary syndrome of menopause.Menopause. 2017; 24: 1360-1364
- Patients' Perspectives and Advice on How to Discuss Sexual Orientation, Gender Identity, and Sexual Health in Oncology Clinics.Am J Hosp Palliat Care. 2020; 37: 1053-1061
- Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers.Am J Hosp Palliat Care. 2020; 37: 418-423
- Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.Climacteric. 2015; 18: 121-134
- Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study.Breast Cancer Res Treat. 2012; 135: 603-609
- Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).Support Care Cancer. 2018; 26: 1335-1343
- Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.Maturitas. 1996; 23: 259-263
- Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial.JAMA Intern Med. 2018; 178: 681-690
- Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.J Clin Oncol. 1997; 15: 969-973
- A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.Support Care Cancer. 2021; 29: 311-322
- Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study.Menopause. 2018; 25: 657-662
- Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.Support Care Cancer. 2020; 28: 3669-3677
- Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy.Menopause. 2019; 26: 423-427
- Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial.JAMA. 2021; 326: 1381-1389
- Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy.J Oncol Pract. 2019; 15: 363-370
- Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.J Cancer Surviv. 2009; 3: 223-232
- Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.J Clin Oncol. 2012; 30: 3578-3587
- Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.J Clin Oncol. 2020; 38: 1875-1886
- Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.J Clin Oncol. 2012; 30: 274-281
- Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.J Clin Oncol. 2014; 32: 2031-2038
- Renaming "chemobrain.Cancer Invest. 2007; 25: 373-377
- Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.Explore (NY). 2012; 8: 127-135
- Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.J Clin Oncol. 2021; 39: 3283-3292
- Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.Cancer. 2018; 124: 192-202
- The effect of EEG biofeedback on reducing postcancer cognitive impairment.Integr Cancer Ther. 2013; 12: 475-487
- Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.Cancer. 2020; 126: 5328-5336
- Advanced cognitive training for breast cancer survivors: a randomized controlled trial.Breast Cancer Res Treat. 2012; 135: 799-809
- The effect of modafinil on cognitive function in breast cancer survivors.Cancer. 2009; 115: 2605-2616
- Use of methylphenidate in patients with cancer.Am J Hosp Palliat Care. 2006; 23: 35-40
- Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.J Clin Oncol. 2007; 25: 3877-3883
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Breast Cancer Res Treat. 2008; 111: 365-372
- Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.Oncology (Williston Park). 2008; 22: 1401-1408
- Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.J Clin Oncol. 2015; 33: 1104-1111
- Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.J Clin Oncol. 2015; 33: 1910-1917
- Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).Breast Cancer Res Treat. 2018; 172: 603-610
- Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.JAMA. 2018; 320: 167-176
- Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.J Clin Oncol. 2018; 36: 326-332
- Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation.J Clin Oncol. 2014; 32: 1840-1850
- NCCN Clinical Practice Guidelines Cancer-related fatigue.J Natl Compr Canc Netw. 2010; 8: 904-931
- Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial.J Clin Oncol. 2012; 30: 1335-1342
- Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial.J Clin Oncol. 2014; 32: 1040-1049
- Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial.Cancer. 2012; 118: 3766-3775
- Yoga effectively reduces fatigue and symptoms of depression in patients with different types of cancer.Support Care Cancer. 2021; 29: 2973-2982
- Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.J Natl Cancer Inst. 2013; 105: 1230-1238
- Adverse effects of herbal medicines: an overview of systematic reviews.Clin Med (Lond). 2013; 13: 7-12
- Aromatase inhibitor therapy and hair loss among breast cancer survivors.Breast Cancer Res Treat. 2013; 142: 435-443
- Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?.Tumori. 2015; 101: 469-473
- Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.JAMA Dermatol. 2018; 154: 670-675
- Oral minoxidil fo rthe treatment of late alopecia in cancer survivors, Abstract #12022.Am Soc Clin Oncol Annu Meet. 2022; 2022
- Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis.J Clin Oncol. 2005; 23: 8570-8579
- Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter.Int J Radiat Oncol Biol Phys. 2013; 85: 604-608
- Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).Eur J Cancer. 2009; 45: 2488-2495
- Radiation-induced Breast Telangiectasias Treated with the Pulsed Dye Laser.J Clin Aesthet Dermatol. 2014; 7: 34-37
- Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom.J Cancer Surviv. 2021; 15: 564-575
- Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom.Plos Med. 2021; 18: e1003504
- Survivors of breast cancer: patient perspectives on survivorship care planning.J Cancer Surviv. 2011; 5: 337-344
- A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients.Psychooncology. 2018; 27: 1695-1703
- Cognitive Behavioral Therapy for Insomnia in Breast Cancer Survivors: A Review of the Literature.Front Psychol. 2016; 7: 1162
- Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review.Eur Med J Oncol. 2013; 1: 106-115
- The effects of Tai Chi on quality of life of cancer survivors: a systematic review and meta-analysis.Support Care Cancer. 2019; 27: 3701-3716
- Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.J Natl Cancer Inst. 2003; 95: 1758-1764
- Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.BMJ. 2010; 340: c693
- Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.J Clin Psychiatry. 2009; 70: 1688-1697
- The variable response of women with menopausal hot flashes when treated with sertraline.Menopause. 2007; 14: 841-845
- Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.J Clin Oncol. 2009; 27: 2831-2837
- Nutrition recommendations during and after treatment.American Society of Clinical Oncology. 2022;
- American Cancer Society nutrition and physical activity guideline for cancer survivors.CA Cancer J Clin. 2022; 72: 230-262
- Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.Acta Oncol. 2015; 54: 635-654
- Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis.JNCI Cancer Spectr. 2020; 4: pkz080
- A Meta-analysis of the Association Between Physical Activity and Breast Cancer Mortality.Cancer Nurs. 2019; 42: 271-285
- Epidemiology and biology of physical activity and cancer recurrence.J Mol Med (Berl). 2017; 95: 1029-1041
- Effects of exercise during adjuvant chemotherapy on breast cancer outcomes.Med Sci Sports Exerc. 2014; 46: 1744-1751
- Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival.J Natl Cancer Inst. 2021; 113: 54-63
- Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial.JAMA Intern Med. 2015; 175: 1752-1760
- Vegetarian diets and the incidence of cancer in a low-risk population.Cancer Epidemiol Biomarkers Prev. 2013; 22: 286-294
- Impact of dietary patterns and the main food groups on mortality and recurrence in cancer survivors: a systematic review of current epidemiological literature.BMJ Open. 2018; 8: e014530
- Implementing a low-fat eating plan in the Women's Intervention Nutrition Study.J Am Diet Assoc. 2009; 109: 688-696
- Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.JAMA. 2007; 298: 289-298
- Prolonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010).Cancer Epidemiol Biomarkers Prev. 2015; 24: 783-789
- Prolonged Nightly Fasting and Breast Cancer Prognosis.JAMA Oncol. 2016; 2: 1049-1055
- Dairy, soy, and risk of breast cancer: those confounded milks.Int J Epidemiol. 2020; 49: 1526-1537
- Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).J Clin Oncol. 2020; 38: 804-814
- The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk.Int J Cancer. 2020; 147: 931-939
- Patient experience and attitudes toward addressing the cost of breast cancer care.Oncologist. 2014; 19: 1135-1140
- Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.J Oncol Pract. 2019; 15: e666-e676
- Financial Toxicity During Breast Cancer Treatment: A Qualitative Analysis to Inform Strategies for Mitigation.JCO Oncol Pract. 2021; 17: e1413-e1423
- Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.J Clin Oncol. 2015; 33: 1053-1059
- Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D.J Natl Compr Canc Netw. 2017; 15: 1509-1517
- Cancer survival disparities by health insurance status.Cancer Med. 2013; 2: 403-411
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.J Clin Oncol. 2016; 34: 611-635
- Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.Cancer. 2021; 127: 3310-3324
- Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.J Clin Oncol. 2007; 25: 3871-3876
- Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.J Natl Cancer Inst. 1994; 86: 527-537
- Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.N Engl J Med. 2019; 381: 2091-2102
- Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue.AJR Am J Roentgenol. 2016; 207: 450-457
- Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy.Breast. 2021; 59: 327-338
- Live birth outcomes after adolescent and young adult breast cancer.Int J Cancer. 2018; 142: 1994-2002
- Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.J Clin Oncol. 2013; 31: 4188-4198
- Contemporary Hormonal Contraception and the Risk of Breast Cancer.N Engl J Med. 2017; 377: 2228-2239
- Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.Contraception. 2011; 83: 211-217
- Use of the levonorgestrel-releasing intrauterine system and breast cancer.Obstet Gynecol. 2005; 106: 813-817
- Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.Breast Cancer Res Treat. 2017; 168: 523-530
- Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.Circulation. 2018; 137: e30-e66
- Endocrine therapy plus zoledronic acid in premenopausal breast cancer.N Engl J Med. 2009; 360: 679-691
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.Lancet. 2015; 386: 1353-1361
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.Lancet Oncol. 2020; 21: 60-72
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol. 2019; 20: 339-351
- Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).Support Care Cancer. 2021; 29: 2509-2517
Barrio AV, Montagna G, Sevilimedu V, Gomez EA, Mehrara B, Morrow M. GS4-01. Impact of race and ethnicity on incidence and severity of breast cancer related lymphedema after axillary lymph node dissection: Results of a prospective screening study. Presented at San Antonion Breast Cancer Symposium. 2021.
- Cancer Support Needs for African American Breast Cancer Survivors and Caregivers.J Cancer Educ. 2016; 31: 166-171
- The breast cancer experience of rural women: a literature review.Psychooncology. 2007; 16: 875-887
- After breast cancer: sexual functioning of sexual minority survivors.J Sex Res. 2014; 51: 681-689
- Unmet support needs of sexual and gender minority breast cancer survivors.Support Care Cancer. 2018; 26: 1189-1196
- Cancer's Margins: Trans∗ and Gender Nonconforming People's Access to Knowledge, Experiences of Cancer Health, and Decision-Making.LGBT Health. 2015; 3: 79-89
- American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations.J Clin Oncol. 2017; 35: 2203-2208
- Advancing Health Equity in Cancer Survivorship: Opportunities for Public Health.Am J Prev Med. 2015; 49: S477-S482
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
